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Induction of the Cellular MicroRNA, Hs_154, by West Nile Virus
Contributes to Virus-Mediated Apoptosis through Repression of
Antiapoptotic Factors
Jessica L. Smith,a Finn E. Grey,a* Jennifer L. Uhrlaub,b Janko Nikolich-Zugich,b and Alec J. Hirscha
Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA,a and Department of Immunobiology, University of Arizona, Tucson,
Arizona, USAb
MicroRNAs (miRNAs) are a class of noncoding small RNAs that regulate multiple cellular processes, as well as the replication
and pathogenesis of many DNA viruses and some RNA viruses. Examination of cellular miRNA profiles inWest Nile virus
(WNV)-infected HEK293 and SK-N-MC cells revealed increased expression of multiple miRNA species. One of these miRNAs,
Hs_154, was significantly induced not only inWNV-infected neuronal cells in culture but also in the central nervous system tis-
sues of infected mice and, upon transfection, caused a significant reduction in viral replication. Analysis of mRNA transcripts
enriched through immunoprecipitation of the RNA-induced silencing complex identified several transcripts that contain seed
sequence matches to Hs_154 in their 3= untranslated regions (UTRs). Two of these targets, the CCCTC-binding factor (CTCF)
and the epidermal growth factor receptor (EGFR)-coamplified and overexpressed protein (ECOP/VOPP1) proteins display re-
duced expression inWNV-infected cells, and the 3=UTRs of these transcripts were sufficient to cause downregulation of expres-
sion in infected cells or in cells transfected with Hs_154, findings consistent with miRNA targeting of these transcripts. CTCF
and ECOP have been shown to be associated with cell survival, implicating miRNA-directed repression of these targets inWNV-
induced cell death. Consistent with this hypothesis, expression of these genes inWNV-infected cells results in a reduction in the
number of cells undergoing apoptosis. These observations suggest that induction of Hs_154 expression afterWNV infection
modulates the apoptotic response toWNV and that cellular miRNA expression can be quickly altered duringWNV infection to
control aspects of the host response.
West Nile virus (WNV) is a member of the flavivirus familythat has emerged as a significant threat to the U.S. popula-
tion since its introduction into North America in 1999 (3, 34).
Although the majority of infections remain asymptomatic or
cause mild febrile illness in healthy individuals, viral neuroinva-
sion can result inmeningitis or encephalitis, in some cases leading
to long-termneurologic sequelae with both physical and cognitive
manifestations or death (27). Immunocompromised and aged
populations have been shown to be at greatest risk for neuroinva-
sion and more severe forms of WNV-associated disease (41). To
date, over 30,000 cases of WNV disease have been reported in the
United States (9). Of these, ca. 40% represent cases of WNV neu-
roinvasive disease.
The cellular response to WNV infection involves induction of
the interferon response through the triggering of various patho-
gen-associated molecular pattern recognition receptors, such as
RIG-I/IPS-1, TLR3, and PKR. In addition, WNV infection initi-
ates cellular apoptosis through a variety of caspase-dependent
mechanisms, including induction of the unfolded protein re-
sponse (UPR) (32), interaction of WNV proteins with apoptosis
factors (42, 57, 58), and activation of inflammatory pathways (51).
Cell death via these mechanisms contributes to the neuropatho-
genicity observed in WNV infection (44).
The recent identification and functional characterization of
miRNAs has revealed a previously underappreciated mechanism
of posttranscriptional gene regulation in mammalian cells.
miRNAs are 21- to 23-nucleotide single-stranded RNAs. They are
derived from larger transcripts containing stem-loop structures,
which are processed by the RNase III enzymes Drosha and Dicer
into 22-bp duplexes. A single strand of the duplex (the mature
microRNA [miRNA]) associates with a multiprotein complex
termed the RNA-induced silencing complex (RISC). In this con-
text, the miRNA acts as guide strand, directing the RISC to tar-
geted mRNAs, resulting in inhibition of translation initiation and
destabilization of the mRNA through deadenylation (5). Target-
ing of an individual mRNA is dependent on Watson-Crick base
pairing of nucleotides 2 to 8 of the miRNA (the “seed sequence”)
with a complementary region in the 3= untranslated region
(3=UTR) of the mRNA.
Several of the DNA viruses, most notably members of the her-
pesvirus family, encode miRNAs that function to regulate both
viral and cellular gene expression (reviewed in reference 50). In
general, cytoplasmic RNA viruses such as flaviviruses are not be-
lieved to express their own miRNAs (although small RNAs de-
rived from the viral genome can be identified in infected cells
[38]). However, recent studies have demonstrated that viral infec-
tion can result in changes in expression of cellular miRNAs (9, 24,
33, 42, 45, 55, 58). Several reports have demonstrated that specific
miRNAs can exert positive or negative influences on viral replica-
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tion through direct interaction with viral nucleic acid sequences
(25, 28, 37, 40), while other reports have demonstrated that indi-
vidual miRNAs can affect viral replication via targeting cellular
proteins (24, 50). Because individual miRNAs have the potential
to regulate the expression of multiple mRNAs, the changes in
miRNA expression following viral infection are predicted to have
profound effects on the host response andmay represent either an
arm of the innate response to viral infection ormay be induced by
the virus in order to promote a cellular environment more con-
ducive to viral replication.
We report here changes in cellular miRNA expression induced
by WNV infection and the role that the most highly induced
miRNA, Hs_154, plays in the virus-stimulated apoptosis via
miRNA-mediated repression of two proteins, CCCTC binding
factor (CTCF) and EGFR-coamplified and overexpressed protein
(ECOP). We demonstrate that transfection of a Hs_154 mimic
significantly reduces viral replication, suggesting that induction of
this miRNA is a cellular antiviral response to infection. Since vi-
rus-induced apoptosis itself contributes to WNV-induced patho-
genesis (44), Hs_154, and perhaps additional cellular miRNAs,
may be key factors in directing the pathogenic outcome of WNV
infection in the host.
MATERIALS AND METHODS
Virus strains and cell culture. HEK293 and SK-N-MC cells were grown
in modified Eagle medium (Gibco) supplemented with 10% fetal bovine
serum (FBS; HyClone), 2 mM L-glutamine (Invitrogen), 100 U of peni-
cillin G sodium/ml, 100 g of streptomycin sulfate (Invitrogen)/ml, and
1nonessential amino acids (Gibco).HeLa,Huh7, andHuh7.5 cells were
grown inDulbeccomodified Eaglemedium supplementedwith 10%FBS,
2mM L-glutamine, 100 U of penicillin G sodium/ml, and 100g of strep-
tomycin sulfate/ml.WNV385-99 (55) and dengue virus 2 (NewGuinea C
strain; American Type Culture Collection) were passaged twice on C6/36
cells and purified by centrifugation as previously described (31). Virus
titers were determined using a by focus formation assay. Serial dilutions of
virus were plated on Vero cells and allowed to adsorb for 1 h, followed by
overlay with 0.5% carboxymethyl cellulose (Sigma). At 48 h postinfection
(p.i.), the cells were fixed with 4% paraformaldehyde, washed twice with
phosphate-buffered saline (PBS), blocked, and permeabilized for 1 h in
PBS supplemented with 2% normal goat serum (NGS; Sigma) and 0.4%
Triton X-100. The cells were then incubated with 0.3g of anti-flavivirus
monoclonal antibody 4G2 (22)/ml in PBS supplemented with 2% NGS
for 1 h, washed twice more with PBS, incubated with anti-mouse IgG-
horseradish peroxidase (Santa Cruz Biotech) for 1 h, and washed twice
with PBS. Foci were visualized by incubation using a Vector VIP peroxi-
dase substrate kit (Vector Labs) according to the manufacturer’s specifi-
cations.
All infections were performed by incubation of the virus at the indi-
cated multiplicities of infection (MOIs) in medium supplemented with
2% FBS at a low volume for 1 h with rocking. The cells were then washed
with PBS and refed with complete growth medium.
miRNA microarray. HEK293 cells and SK-N-MC cells were infected
with WNV at a multiplicity of 3 PFU/cell. At 48 h p.i., the total RNA was
isolated with TRIzol (Invitrogen) according to the manufacturer’s proto-
col. RNA was prepared for hybridization using a miRNA expression pro-
filing reagent kit (Illumina) according to the manufacturer’s protocol.
Briefly, 200 ng of total RNAwas polyadenylated with poly(A) polymerase.
The polyadenylated RNA was converted to cDNA using a biotinylated
oligo(dT) primer with a universal PCR sequence at its 5= end. The biotin-
ylated cDNAwas hybridized to chimeric oligonucleotides containing (i) a
universal PCR priming site on the 5= end, (ii) an address sequence that
complements a specific capture sequence on the array, and (iii) amiRNA-
specific sequence. This hybridization complex was recovered using
streptavidin-conjugated paramagnetic beads. The chimeric oligonucleo-
tide was extended with DNA polymerase. The complex was amplified by
PCR using the incorporation of a primer with a fluorescent tag. The PCR
products were hybridized to a miRNA bead array composed of oligonu-
cleotides complementary to the address sequence. The array was scanned
on a BeadArray scanner (Illumina), and the data were prepared using
Genome Studio. The heat map was constructed using Multi-Experiment
Viewer software (43).
Reagents.Where indicated, universal type I interferon (PBL Biomed-
ical Laboratories) was added to cells to a final concentration of 1,000
U/ml. QVD-OPh (RnD Systems, catalog no. OPH001-01M)was added to
20M. The antibodies used here were anti-dicer (Cell Signaling Technol-
ogies, catalog no. 3363), anti-Drosha (Cell Signaling Technologies, cata-
log no. 3364) anti-CTCF (Cell Signaling Technologies, catalog no. 2899S),
anti-FLAG (Sigma, catalog no. F3165), anti--actin (Sigma, catalog no.
A5441), anti-PARP (Cell Signaling Technologies, catalog no. 9532), and
anti-firefly luciferase (Sigma, catalog no. L2164).
Plasmids. The 3=UTRs of CTCF and ECOP were amplified by
PCR (CTCF-A, 5=-ATCCTAGGCTTGTGCGTCGCCAGGACTTC-3=;
CTCF-B, 5=-ATGAGCTCGGAGCACTTGTTAATCCGTTA-3=; ECOP-A,
5=-CTCGAGGTGCAAGAGGAGAGACAGGAG-3=; and ECOP-B, 5=-GC
GGCCGCGCACACATAGGAAACAGGATC-3=), digested, and ligated
directly into pMirKan (Ambion), with the ampicillin cassette replaced
with a kanamycin cassette as previously described (20), or psiCheck2
(Promega). Full-length CTCF and ECOP clones were produced by PCR
amplification (CTCF, 5=-AAGAATTCACCATGGAAGGTGATGCAGTC
GAA-3= and 5=-TTCTCGAGTCACCGGTCCATCATGCT-3=; and
ECOP, 5=-GGAAGCTTATGAGGCGCCAGCCTGCG-3= and 5=-TT
GCGGCCGCCTACTTGTCGTCATCCTTCACTAC-3=). In the case of
ECOP, a Flag tag was incorporated at the 3= end during amplification to
facilitate visualization. PCR products were digested and ligated into
pcDNA3 (Invitrogen).Mutants were produced by site-directedmutagen-
esis ofHs_154 seed sites in CTCF and ECOP 3=UTRs (CTCFm1, positions
431 to 437 of the 3=UTR; CTCFm2, positions 578 to 584; CTCFm3, posi-
tions 264 to 269; ECOPm1, positions 2148 to 2154; ECOPm2, positions
1941 to 1946).
miRNANorthern blotting. Total RNA was separated on a 15% poly-
acrylamide–7 M urea gel, transferred to a GeneScreen Plus membrane
(Perkin-Elmer), and cross-linked to the membrane with UV light. Probes
were prepared by end labeling antisense oligonucleotides (Hs_154, 5=-TC
CTCCCCCTTCCTTTTCCC-3=; Hs_243.1, 5=-TCTCCGCCGGGCCTTC
AC-3=; Hs_188, 5=-TCCGCCGCTCCGCCTTCCGC-3=; miR-16, 5=-CGC
CAATATTTACGTGCTGCTA-3=) with [-32P]dATP (Perkin-Elmer)
using T4 polynucleotide kinase (Fermentas). Probes were hybridized to
membranes overnight at 38°C in PerfectHyb buffer (Sigma) and visual-
ized by autoradiography.
qRT-PCR. Portions (25 ng) of total RNA or RISC-associated RNA
were subjected to quantitative reverse transcription-PCR (qRT-PCR) us-
ing CTCF (Hs00902008_m1)-, ECOP (Hs00697470_m1)-, and GAPDH
(glyceraldehyde-3-phosphate dehydrogenase; Hs99999905_m1)-specific
TaqMan gene expression assays and One-Step RT-PCR reagents on a
StepOne Plus real-time PCR machine (Applied Biosystems) according to
the manufacturer’s instructions. The relative expression in samples was
calculated by theCTmethodusingGAPDHas the endogenous control.
RISC-IP. RISC-immunoprecipitation (RISC-IP) analysis was carried
as out previously described (26). HEK293 cells stably transfected with
c-myc-tagged argonaute 2 (Ago2) protein were infected with WNV at a
multiplicity of 3 PFU/cell. At 48 h postinfection, the cells were lysed, and
Ago2 and associated proteins and RNAs were immunoprecipitated using
anti-c-myc antibody beads (Sigma). Immunoprecipitations were per-
formed in duplicate using biological replicates. RNA was isolated using
TRIzol and analyzed for quality by using an Agilent Bioanalyzer, and
transcript levels were determined on an Illumina HumanRef-6 platform.
Microarray data were analyzed using Gene Sifter software (Geospiza).
Enrichment of specific transcripts, through associationwithmiRNA-pro-
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tein complexes was determined by dividing the immunoprecipitated lev-
els of transcripts by the total levels as previously described (21).
Infection and analysis of mice. B6.129S7-Rag1tm1Mom/J mice (33)
were purchased from The Jackson Laboratory (Bar Harbor, ME), bred at
the VGTI Vivarium (Oregon Health and Science University [OHSU]),
and used at 12 weeks of age. All animals were housed and bred under
specific-pathogen-free conditions at OHSU. All WNV experiments were
completed within a U.S. Department of Agriculture-approved biosafety
level 3 facility and were approved by the Institutional Animal Care and
Use Committee (permit 0724) and the Institutional Biosafety Committee
in accordancewith the applicable federal, state, and local regulations. This
study was carried out in strict accordance with the recommendations of
the Guide for the Care and Use of Laboratory Animals (National Institutes
of Health). Mice were infected with 250 PFU ofWNV subcutaneously. At
days 3 and 11 p.i., they were sacrificed, the brains were collected and
homogenized, and the total RNA was isolated using TRIzol. Immunoflu-
orescent staining was performed as previously described (31).
siRNA, miRNA, and plasmid transfections. Small interfering RNAs
(siRNAs) against Dicer and Drosha proteins (Applied Biosystems) were
transfected into HEK293 cells with RNAiMAX reagent (Invitrogen).
miRNA duplexes were synthesized by Integrated DNA Technologies and
transfected using RNAiMAX reagent. The antisense locked-nucleic-acid
(LNA) Hs_154 inhibitor (Exiqon; listed as the hsa-miRPlus-F1050
miRCURY LNA microRNA power inhibitor) and negative control (Ex-
iqon; miRCURY LNA microRNA power inhibitor control, negative con-
trol A) were transfected with RNAiMAX and 50 nM LNA inhibitor.
Poly(I:C) (Sigma, catalog no. P9582) transfections were performed with
2.5g of poly(I:C)/ml and Lipofectamine LTX reagent (Invitrogen). Plas-
mids expressing CTCF and ECOP cDNAs were transfected using FuGene
reagent (Roche). All transfections were carried out according to the man-
ufacturer’s recommendations. Unless otherwise stated, samples were pro-
cessed or infected at 48 h posttransfection. Cotransfections with Hs_154
miRNA duplex and psiCheck reporter plasmids were performed with Li-
pofectamine 2000 and processed for luciferase detection at 24 h posttrans-
fection.
Luciferase assays. HEK293 cells transfected with psiCheck2 reporter
plasmids andnegative control/Hs_154were lysed at 24 h posttransfection.
Luciferase assays were performed using a dual luciferase reporter assay
system (Promega) according to the manufacturer’s recommendations.
TUNEL assay.Control, CTCF, ECOP/FLAG, control LNA, orHs_154
LNA-transfected cells were infected with WNV at 48 h posttransfection.
The cells were fixed at 48 h p.i. and stained for apoptotic cells using the
DeadEnd Fluorimetric TUNEL system (Promega). The number of
TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin
nick end labeling)-positive cells per frame was determined using ImageJ
software.
miRNA annotation in miRBase. The sequences for Hs_154, Hs_188,
and Hs_243 have been submitted to the public miRNA database miRBase
(www.mirbase.org) and assigned the following names: Hs_154, hsa-mir-
6124; Hs_188, has-mir-6125; and Hs_243, hsa-mir-6126.
RESULTS
WNV infection alters the expression level of multiple cellular
miRNAs. In order to examine the effect of WNV infection on
miRNA expression, HEK293 and SK-N-MC cell lines were in-
fected at a multiplicity of 3 PFU/cell, RNA was collected at 48 h
p.i., andmiRNA expressionwas examined bymiRNA-specificmi-
croarray. This time postinfection has been reported to showmax-
imal changes in mRNA expression relative to uninfected cells,
including strong induction of multiple interferon-responsive
genes (17). In parallel, we also treated both cell lines with type I
interferon and analyzed RNA from these cells at 6 h posttreat-
ment, at which time we would expect to see increased expression
of multiple miRNAs (40). We observed differential expression of
multiple miRNAs in WNV-infected cells compared to uninfected
controls (Fig. 1A and Files S1 and S2 in the supplemental mate-
rial). Surprisingly, the most highly induced miRNAs following
WNV infection did not correspond to those upregulated after
interferon treatment, suggesting that the induction observed is
WNV specific or due to a cellular pathway distinct from the inter-
feron response to viral infection. Induction of the interferon re-
sponse was confirmed by qRT-PCR analysis of interferon-stimu-
lated gene 54 (ISG54) expression (data not shown). Interestingly,
several of the most highly induced miRNAs (e.g., Hs_154,
Hs_243, and Hs_188; Fig. 1 and Table 1) in WNV-infected
HEK293 and SK-N-MC cells were previously identified as low-
abundance miRNAs present in RNA derived from fetal brain and
other human tissues (6, 7). Upregulation of these miRNAs was
confirmed by Northern blotting (Fig. 1B). Expression of miR-16
appeared to be unchanged followingWNV infection and serves as
a loading control.
To confirm that Hs_154 is produced through the canonical
miRNA biogenesis pathway, the effect of siRNA knockdown of
two essential factors of miRNA formation, Dicer and Drosha, on
Hs_154 induction by WNV was examined. Western blot analysis
indicated efficient knockdown of Dicer and Drosha following
siRNA transfection (Fig. 1D). As shown (Fig. 1C), depletion of
Dicer or Drosha diminished the ability ofWNV to induce Hs_154
expression. It has previously been shown that the average miRNA
half-life is approximately 5 days (18), so miRNAs present at high
levels before siRNA transfection and subsequent WNV infection
are not predicted to show dramatic changes in expression. Con-
sistent with this, miR-16 levels appeared to be unaffected by Dicer
and Drosha knockdown. These results confirm that Dicer and
Drosha activity are required for Hs_154 expression following
WNV infection. The signal for Hs_154 appears as a doublet,
indicating a 21- to 22-nucleotide (nt) form, as well as slightly
larger form. This may be due to heterogeneity at the miRNA 3=
ends, a phenomenon frequently observed in miRNA biogenesis
(30, 47, 54).
To assess the effect of Hs_154 on viral replication, a double-
stranded RNA designed to specifically load the mature Hs_154
sequence into the RISC (46, 49) was transfected in to HeLa and
SK-N-MC cells, followed by infection with WNV. Expression of
Hs_154 significantly reduced virus titers at days 2 and 3 p.i. in
HeLa (Fig. 2A) and SK-N-MC cells (Fig. 2B), demonstrating an
antiviral role for this miRNA. Due to the particularly strong in-
duction of this miRNA by WNV infection and its effect on viral
replication, the requirements for induction of Hs_154 and its
downstream targets were investigated further.
Hs_154 is induced by WNV in multiple cell types, with late
kinetics, and occurs in vivo. To determine whether Hs_154 up-
regulation byWNV is a cell-type-specific phenomenon, the effect
of WNV infection on Hs_154 levels was examined in other cell
types. The neuroblastoma-derived cell line SK-N-MCalso showed
Hs_154 induction in the microarray, and this induction was con-
firmed by Northern blot analysis (Fig. 3A). We also examined
Hs_154 induction in Huh7 cells (a hepatocellular carcinoma-de-
rived cell line) and its derivative Huh7.5, which carries amutation
inactivating the double-stranded RNA sensor RIG-I (48). Hs_154
induction by WNV infection was observed in these cell types as
well (Fig. 3A), indicating that induction of Hs_154 expression
does not require a RIG-I-dependent pathway.We next performed
a time course experiment of WNV-infected cells to establish how
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early after infection this Hs_154 is expressed. As shown, Hs_154
upregulation was not observed at 24 h p.i. but was detected at 36 h
p.i., with the strongest induction at 48 h p.i. (Fig. 3B).
In order to determine whether Hs_154 induction occurs in vivo,
we examined Hs_154 expression in the brains of WNV-infected
mice. A hairpin structure homologous to that encoding Hs_154 in
humans has been identified in mice, suggesting that Hs_154 expres-
sion is conserved in mammals (6). We infected Rag/mice, which
are exquisitely sensitive to WNV and show a high percentage of in-
fection within the neurons of the brains by day 9 p.i. (Fig. 3D).
Rag/ mice were infected with WNV, and the total RNA was iso-
lated from the brains of individual mice at days 3 and 11 p.i. Hs_154
was not detected in the brains of uninfectedmice or inmice at 3 days
p.i. In contrast, high levels of Hs_154 were observed at day 11 p.i.,
indicating that the induction of Hs_154 occurs in vivo and correlates
temporally withWNV pathogenesis (Fig. 3C).
Hs_154 is not induced by interferon, double-stranded RNA,
or other flaviviruses and is independent of caspase activity.
Since the induction of Hs_154 by WNV appears to be a cellular
response to infection, one might expect that other treatments,
such as antiviral cellular pathways or related viral infections,
might also result in increased expression of this miRNA. There-
fore, we examined Hs_154 levels after treatment with triggers
of antiviral pathways that are activated byWNV infection. Nei-
ther poly(I:C) transfection to activate RIG-I nor treatment
with recombinant interferon resulted in the induction of
Hs_154 (Fig. 4A), a finding consistent with the observed induc-
tion of Hs_154 in Huh7.5 cells (Fig. 3A) and the previously
discussed results of the microarray (Fig. 1A). In addition,
Hs_154 was not upregulated after infection of HEK293 cells
with dengue virus (DENV), another member of the flavivirus
family (Fig. 4B). DENV replication proceeds more slowly than
WNV in HEK293 cells, so cells were examined through 72 h p.i.
FIG 1 WNV alters expression of cellular miRNAs. (A) Heat map analysis showing cellular miRNA expression after the indicated treatment. Values indicate
increased (red) or decreased (green) expression ofmiRNAs versus controls and are ranked in descending order based on the fold change inHEK293 cells infected
with WNV. The 25 miRNAs showing the greatest induction of expression and the 25 miRNAs showing greatest repression of expression in WNV-infected
HEK293 cells relative to uninfected controls are shown. miRNAs annotated “Hs” are described in references (6, 7). The annotation “0.1” appended to some
indicates those described in reference 7. Cells were infected withWNV at amultiplicity of infection (MOI) of 3 PFU/cell or treated with type I interferon. At 48 h
p.i., total RNA was extracted, and miRNA expression was analyzed by microarray. For interferon treatment, the cells were harvested at 6 h posttreatment.
Expression values and the fold change are provided in Files S1 and S2 in the supplemental material. (B) HEK293 cells were mock treated or infected at an MOI
of 3 PFU/cell. Total RNA was subjected to denaturing gel electrophoresis and probed for the indicated miRNAs using end-labeled antisense oligonucleotide
probes. miR-16 was detected as a loading control. (C) The effects of siRNA knockdown of the RNases, Dicer and Drosha, on Hs_154 induction were detected by
siRNA transfection of HEK293 followed byWNV infection (MOI 3 PFU/cell) at 48 h posttransfection. The total RNA was extracted at 48 h p.i. and analyzed
by Northern blotting. Arrows indicate pre-miRNA (top) and mature miRNA (bottom) species. (D) Western blots demonstrating knockdown of Dicer and
Drosha proteins following siRNA transfection.
TABLE 1 Sequences of miRNAs induced by WNV
miRNA designation miRNA mature sequence (5=-3=) Reference
Hs_154 GGGAAAAGGAAGGGGGAGGA 6
Hs_188 GCGGAAGGCGGAGCGGCGGA 6
Hs_243 GTGAAGGCCCGGCGGAGA 7
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(peak replication is achieved at between 48 and 72 h p.i.).
Poly(I:C) transfection, interferon addition, and DENV infec-
tion all induced ISG54 expression, verifying that the cells re-
sponded to these stimuli as expected (data not shown). Since
the strongest Hs_154 induction by WNV was at 48 h p.i., at
which time highly cytopathic effect can be observed and the
cells are undergoing apoptosis (32), we hypothesized that
apoptosis activation by WNV infection could be related to the
induction of Hs_154 expression. Thus, we determined whether
increased expression of this miRNA was a downstream effect of
WNV-induced apoptosis. The cells were infected with WNV in
the presence or absence of QVD-OPh, a caspase inhibitor pre-
FIG 2 Hs_154 expression inhibits WNV replication. HeLa (A) or SK-N-MC cells (B) were transfected with a negative control miRNA (black squares) or a
double-stranded RNA mimic of Hs_154 (gray triangles). At 48 h posttransfection, the cells were infected with WNV at an MOI of 5 PFU/cell (HeLa) or 0.01
PFU/cell (SK-N-MC). Supernatants were collected at 1, 2, and 3 days p.i., and titers were determined on Vero cells. Titers are shown are averages of three
biological replicates the SD. Significant reductions in virus titers were detected at day 2 (HeLa, P 0.05; SK-N-MC, P 0.005) and day 3 (HeLa, P 0.001;
SK-N-MC, P 0.05) postinfection in Hs_154-transfected cells. P values were determined by Student t test.
FIG 3 Hs_154 is induced with late kinetics in multiple cell types and in WNV-infected mouse brains. (A) HEK293, SK-N-MC, Huh7, and Huh7.5 cells were
mock treated or infected withWNV at anMOI of 3 PFU/cell, and the total RNAwas extracted at 48 h p.i. and subjected to Northern blot analysis for Hs_154. (B)
HEK293 cells were infected withWNV (MOI 3 PFU/cell). At the indicated times postinfection, RNAwas isolated from infected cells and analyzed for Hs_154
levels. (C) RNA was isolated from the neural tissue of WNV-infected rag/mice at the indicated times postinfection, and Hs_154 and miR-16 expression was
analyzed byNorthern blotting. (D) Paraffin-embedded brain from amoribundWNV-infected adult rag/mouse was sectioned and immunostained forWNV.
Strong green fluorescent labeling of all neuronal soma in the hippocampal cortex (dentate gyrus [DG] and pyramidal neurons [PN]) was detected. Adjacent
neocortex (CTX) shows similar strong labeling of neuronal soma in all cortical layers. Bar, 50 m.
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viously demonstrated to inhibitWNV-induced apoptosis with-
out affecting infection (44). Treatment with QVD-OPh did not
inhibit Hs_154 upregulation by WNV (Fig. 4C, top panel),
suggesting that Hs_154 induction is either unrelated to or oc-
curs upstream of caspase activation. Cleavage of the caspase
substrate poly(ADP-ribose) polymerase (PARP) in WNV-in-
fected cells and inhibition of PARP cleavage by QVD-OPh were
confirmed by Western blotting (Fig. 4C, bottom panel).
CTCF and ECOP are targets of Hs_154 in WNV-infected
cells. miRNA target identification is complicated by the fact that
miRNA-mRNA interactions commonly occur through comple-
mentarity of as few as 7 bp. Thus, bioinformatic approaches often
produce a high number of false-positive results. Therefore, we
used RISC-IP to determine whichmRNAs are specifically targeted
by miRNAs during WNV infection. HEK293 cells expressing a
myc-tagged Ago2 protein (26) were mock infected or infected
withWNV, and RISC-IP was performed with an antibody specific
for the myc epitope tag. Total and RISC-associated RNA were
isolated and analyzed by microarray. The presence of an individ-
ualmRNA at a higher level in the IP fraction compared to the total
RNA is indicative of the mRNA being associated with the RISC.
Since targeting of mRNAs to the RISC is most commonly medi-
ated by complementarity between the miRNA seed site (nt 2 to 8)
and nucleotides within the 3=UTR of the targeted gene, we exam-
ined the 3=UTRs of highly enriched mRNAs following WNV in-
fection for Hs_154 seed site matches. The presence of several seed
site matches within a 3=UTR, coupled with a high degree of con-
servation of these sequences, suggests that these mRNAs are in-
deed Hs_154 targets. Table 2 displays the top 20 RISC-enriched
mRNAs containing matches to the Hs_154 seed site, the level of
enrichment within the RISC following WNV infection, the num-
ber of Hs_154 seed site matches found in the 3=UTR of these
genes, and whether or not these matches are conserved across
species. Two genes, CTCF and ECOP, were determined to have
several highly conserved Hs_154 seed site matches within their
3=UTRs andwere chosen for further investigation. To confirm the
RISC association of these mRNAs, RNA was isolated using an
independently performed RISC-IP, and the CTCF and ECOP
mRNAs were quantified by qRT-PCR. Both CTCF and ECOP
mRNAs showed enrichment in the immunoprecipitated fraction
(Fig. 5). Interestingly, ECOP mRNA appears to be enriched (i.e.,
RISC associated) in uninfected cells as well, which is consistent
with previous reports demonstrating targeting of the ECOP by
miR-218 (19).
In order to determinewhetherCTCF andECOPwere targets of
Hs_154, the mRNA 3=UTRs of CTCF and ECOP were inserted
downstreamof a luciferase reporter, andHEK293 cells were trans-
fected with these or control (i.e., no exogenous 3=UTR) luciferase
expression vectors. At 48 h posttransfection, the cells were in-
fected with WNV, and the total protein was analyzed by Western
blotting for luciferase expression at 48 h p.i. WNV infection re-
sulted in a reduction in the expression of luciferase from vectors
bearing CTCF or ECOP—but not control—UTRs (Fig. 6A). In
addition, the three expression vectors were transfected together
with an RNA duplex designed to mimic the mature Hs_154 se-
quence or a controlmiRNA, and total proteinwas analyzed at 48 h
posttransfection. Inclusion of the 3=UTRs of both CTCF and
ECOPdownstreamof luciferase caused downregulation following
Hs_154 duplex transfection (Fig. 6B), demonstrating that both of
these genes are downstream targets of theWNV-inducedmiRNA,
Hs_154. Consistent with these observations, bothWNV infection
andHs_154 duplex transfection resulted in the downregulation of
endogenous levels of CTCF protein at 48 h posttreatment (Fig. 6C
FIG 4 Hs_154 induction is independent of interferon, dsRNA, other flaviviruses, and caspase activation. (A) The effects of poly(I:C) (2.5 g/ml) or interferon
(3,000 U/ml) treatment on Hs_154 levels were determined by Northern blot analysis. (B) HEK293 cells were infected with WNV or DENV at an MOI of 3
PFU/cell. RNAwas extracted at indicated times postinfection and analyzed for Hs_154 by Northern blotting. (C) HEK293 cells were treated with QVD-OPh and
infected with WNV at a multiplicity of 3 PFU/cell. RNA was extracted at 48 h p.i. and analyzed by Northern blotting.
TABLE 2 Genes enriched in the RISC in WNV-infected cells containing
Hs_154 seed matchesa
Gene
RISC-IP
enrichment
No. of Hs_154
seed site
matches in
3=UTR
Seed site match
conservation
PCNA 3.4787 1 Yes
C20ORF95/ARHGAP40 2.3271 2
NPHP1 2.3211 1 No
ECOP 2.3001 2 Yes
CTCF 2.2306 3 Yes
C6ORF78/FAM26D 2.2302 1 No
C10ORF63/ENKUR 2.2096 3 No
LOC440957 2.1951 1 Yes
APP 2.1775 2 Yes
FLJ32679/GOLGA8F 2.1653 1
SS18 2.1539 1 Yes
MGC13017 2.1255 1 No
ZMAT3 2.1066 1 No
SORBS2 2.0874 2 No
FOXD4 2.0836 1 No
MTMR12 2.0829 1 No
WDR61 2.0636 1 No
IL-33 2.0080 4 Yes
CCDC56 2.0026 1 No
a Genes showing2-fold enrichment in the RISC-associated fraction following RISC
immunoprecipitation and microarray analysis were examined for seed matches within
the 3=UTR. The number of potential seed matches is indicated, as well as conservation
in other species. Seed matches were considered conserved if a corresponding sequence
was identified in the 3=UTR of the gene from one or more of the following:
chimpanzees, rhesus macaques, mice, rats, and chickens.
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and D). Finally, CTCF has three potential seed sequence matches
to Hs_154, while ECOP has two such matches (see Fig. S1 and S2
in the supplemental material). Although mutation of individual
sites in the 3=UTR of CTCF did not significantly restore luciferase
expression in cells transfected with Hs_154, mutation of all three
sites returned luciferase expression to levels equivalent to cells
transfected with the negative control miRNA (Fig. 6E). Interest-
ingly, mutation of one of the Hs_154 seed matches in the ECOP
3=UTR fully restored luciferase expression, whereas mutation of
the other resulted in a partial restoration of expression (Fig. 6F).
Expression of CTCF and ECOP inhibit WNV-dependent in-
duction of apoptosis. CTCF and ECOP have been shown to have
antiapoptotic, prosurvival functions in which downregulation of
these genes results in cellular apoptosis (15, 29, 39). Since the time
course of induction of Hs_154 by WNV coincides with virus-
mediated apoptosis, we hypothesized thatHs_154 upregulation in
response to WNV infection leads to the downregulation of these
two genes and contributes to subsequent cell death. This hypoth-
esis predicts that expression of these proteins will protect cells
from WNV-mediated apoptosis. In order to test this hypothesis,
CTCF- and Flag-tagged ECOP-expressing vectors were trans-
fected into HEK293 cells, followed by WNV infection. Total pro-
tein was collected at 48 h p.i. and analyzed for PARP cleavage by
Western blotting. As expected, WNV infection induced PARP
cleavage in cells transfected with the empty expression vector
(pcDNA3). In contrast, expression of CTCF and ECOP signifi-
cantly reduced PARP cleavage (Fig. 7A) after WNV infection. In
parallel, the effects of CTCF and ECOP expression on WNV-in-
duced apoptosis were also investigated by TUNEL assay (Fig. 6B
and C). SK-N-MC cells transfected with CTCF and ECOP expres-
sion vectors were infected with WNV and, at 48 h p.i., were fixed
and stained. As shown in Fig. 7, WNV infection significantly in-
creases the number of apoptotic cells in cultures transfected with
the control vector but not in cells transfectedwithCTCFor ECOP.
Finally, an antisense LNA inhibitor (36) ofHs_154was transfected
into cells, followed by WNV infection and TUNEL staining. In
FIG 5 CTCF and ECOP mRNA association with RISC is enhanced in WNV-
infected cells. Total RNA (black bars) or RNA immunoprecipitated with the
RISC from WNV or mock-infected cells was analyzed by qRT-PCR to deter-
mine the relative levels CTCF and ECOP mRNA. mRNA levels were normal-
ized to -actin mRNA and expressed relative to the expression in total RNA
from uninfected cells. Values represent the averages of two biological repli-
cates.
FIG 6 CTCF and ECOP, targets of Hs_154, are repressed after WNV infection
and Hs_154 transfection. HEK293 cells were transfected with luciferase reporter
plasmids encoding control, CTCF, or ECOP 3=UTRs. At 48 h posttransfection,
cells were infected with WNV at an MOI of 3 PFU/cell (A) or transfected with a
double-stranded RNA corresponding to Hs_154 (B). Protein was isolated at 48 h
p.i. and subjected to Western blot analysis with antibodies to firefly luciferase or
-actin. Endogenous levels of CTCF were analyzed by Western blotting after
WNV infection (C) orHs_154 transfection (D). Relative protein levels compared
to untreated controls normalized to -actin were determined by using ImageJ
software and shownbelow individual bands. Luciferase reporter vectors encoding
CTCF(E)orECOP(F)3=UTRswithseedsequence sitesmutated individuallyor in
combination to disrupt Hs_154 targeting were transfected intoHEK293 cells.Re-
nilla (test) and firefly (control) luciferase activity was measured after transfection
with a negative control or Hs_154. Values represent the averages of three repli-
cates the standard deviations.
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contrast to the control LNA, the Hs_154 inhibitor significantly
reduced the number of apoptotic cells in WNV-infected cultures
(Fig. 7B and C). Taken together, these results indicate that CTCF
and ECOP expression block WNV-induced apoptosis and that
downregulation of these proteins by Hs_154 contributes to apop-
tosis of the infected cell.
DISCUSSION
We have identified multiple miRNAs that display altered expres-
sion followingWNV infection. One such miRNA, Hs_154, which
is strongly induced by WNV and whose expression significantly
inhibits viral replication, was shown to target two antiapoptotic
proteins, CTCF and ECOP. Indeed, the expression of CTCF and
ECOP blocked apoptosis in WNV-infected cells, demonstrating
that the downregulation of expression of these proteins is critical
to the induction of apoptosis. Our results therefore demonstrate
that cellular miRNAs can be mobilized during viral infection to
influence the response of the cell.
Several of the miRNAs displaying altered expression levels in
WNV-infected cells have been previously identified as low-abun-
dance miRNAs in various tissue types using massively parallel se-
quencing or bioinformatics, followed by RNA-primed array-
based Klenow extension (RAKE) analysis (6, 7). Our results
confirm that thesemiRNAs are expressed at relatively low levels in
uninfected cells but are strongly induced during WNV infection.
Hs_154 demonstrates similar induction patterns in multiple
WNV-infected cell types, as well as in the neural tissues of WNV-
infected mice. Interestingly, induction of this miRNA is not ob-
served after treatment of cells with interferon, poly(I:C), or
DENV, suggesting that the expression of Hs_154 is driven by a
pathway unique to WNV. It is possible that Hs_154 induction is
due, in part, to the particularly robust growth of WNV in the cell
types examined. In general,WNVgrowswith faster kinetics and to
higher titers than DENV in HEK293 cells, which may be required
for detectable Hs-154 induction. In addition, in contrast to previ-
ously published results (40), we observed little miRNA induction
following interferon treatment, although other reports have re-
ported a similar lack of change in miRNA expression in the pres-
ence of interferon (30).
Examples of miRNAs that respond to viral infection and affect
viral replication include those believed to target viral sequences
directly (23, 28, 37, 40), as well as those that target host proteins to
modulate the cellular environment and thereby influence viral
replication. Several miRNAs with antiviral activity have been de-
scribed.miR-100 andmiR-101 have been demonstrated to inhibit
human cytomegalovirus (HCMV) replication via inhibition of the
mammalian target of rapamycin (mTOR) pathway (52), and
miR-27 has been shown to block murine cytomegalovirus
(MCMV) replication (8). Notably, these miRNAs are downregu-
lated during HCMV and MCMV infection, respectively, suggest-
ing that these viruses have evolved to manipulate cellular miRNA
expression to promote their replication. Furthermore, a large
screen of miRNA mimics and antagonists identified several
miRNAs that affected the replication of multiple viruses, includ-
ing miRNAs that demonstrate proviral and others that show an-
tiviral activity (45). One of these, miR-199a-3p, was active against
a range of viruses, inhibiting the replication of several members of
the herpesvirus family, as well as of Semliki Forest virus, amember
of the alphavirus family of positive-sense RNA viruses. This
miRNAhas been hypothesized to function throughmodulation of
the mitogen-activated protein kinase pathway, although other
studies have suggested that it can inhibit hepatitis B virus and
hepatitis C virus replication through direct interactions with the
viral genomes (35, 59).
We have identified mRNA transcripts enriched in the RISC
(i.e., targeted by miRNAs) in WNV-infected cells, and we noted
several with potential seed sequence matches to Hs_154. Two of
these mRNAs encode the proteins CTCF and ECOP, both of
which have been reported to have antiapoptotic activity (15, 29,
39). CTCF is a DNA-binding zinc-finger protein involved in the
regulation and maintenance of chromatin domains. Its antiapop-
totic function has been hypothesized to occur via the repression of
transcription of proapoptotic genes, such as Bax (15). Loss of
ECOP expression has been correlated with an increase in reactive
oxygen species andmitochondrial dysfunction (4). Depending on
the cell type and culture conditions, loss of ECOP may also con-
tribute to decreased NF-B activity and subsequent apoptosis
(39). We have confirmed that the Hs_154 seed matches in the
3=UTRs of the CTCF and ECOP mRNAs do indeed mediate
Hs_154-dependent repression of protein expression. Further-
more, endogenous CTCF protein expression was downregulated
by WNV infection or Hs_154 transfection, which is consistent
with a role for Hs_154 in downregulating the expression of these
proteins during infection. Finally, we observed that expression of
FIG 7 Overexpression of CTCF or ECOP or a Hs_154-targeting LNA protects cells from WNV-mediated apoptosis. (A) HEK293 cells were transfected with
empty vector (control) or plasmids encoding CTCF or FLAG-tagged ECOP. At 48 h posttransfection, cells wereWNV infected (MOI 3 PFU/cell), and protein
was isolated at 48 h p.i. forWestern blot analysis of PARP cleavage (arrow), CTCF, FLAG-ECOP, and -actin. (B) SK-N-MC cells were transfected as in panel A
or transfected with a control LNA orHs_154-targeting LNA and infected at anMOI of 3 PFU/cell. Cells were analyzed by TUNEL assay for apoptotic cells at 48 h
p.i. The top panel represents total cells (blue). The bottom panel shows TUNEL-positive cells (green). (C) The number of TUNEL positive cells per frame was
quantified by using ImageJ software (National Institutes of Health).
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CTCF and ECOP blocks apoptosis in WNV-infected cells, sup-
porting the hypothesis that the reduction of expression of these
proteins is necessary for efficient completion of the apoptotic pro-
cess.
Multiple miRNAs have been shown to impact apoptosis (re-
viewed in reference 53). Several miRNAs possessing antiapoptotic
activity, such as miR-21, have been shown to be overexpressed in
a variety of human cancers and to target numerous mRNAs en-
coding proapoptotic host proteins (10, 16, 24). Inhibition of
apoptosis is also the function of several miRNAs encoded by her-
pesviruses, which establish long-term latent or persistent infec-
tions (1, 12, 56). In contrast, other miRNAs have been shown to
promote apoptosis through targeting of prosurvival proteins,
such as Bcl-2, and are often deleted or downregulated in human
cancers. miR-15a, miR-16, and the miR-34 family of miRNAs
have been shown to fall into this class (11, 13).
WNV has previously been shown to induce apoptosis in in-
fected cells through multiple mechanisms. Expression of the viral
nonstructural proteins results in activation ofmultiple arms of the
UPR, induction of the cyclic AMP response element-binding tran-
scription factor homologous protein (CHOP), and caspase acti-
vation (2, 32). Apoptosis has also been shown to be mediated in a
paracrine fashion in infected brains via secretion of neurotoxic
factors by infected astrocytes (51). Inmost cases of viral infection,
the apoptotic response is considered an antiviral mechanism by
which infected cells are deleted and targeted for phagocytosis by
macrophages or other phagocytic cells (14). Consistent with this
mechanism, we observed an inhibitory effect of Hs_154 on viral
replication, implicating Hs_154 induction as an aspect of the host
antiviral response. We detected Hs_154 in abundant amounts in
infected brains from rag/ mice, showing that neurons in vivo
utilize this pathway inWNV infection. Although it is possible, and
even likely, that the absence of the fully functional immune system
in these mice makes this phenomenon more pronounced, we are
confident that the upregulation of Hs_154 is a primary cellular
response to WNV infection. We note that although Hs_154 (and
apoptosis)may demonstrate and antiviral effect in cell culture, the
results of cellular apoptosis following viral infection may, in fact,
be detrimental to the host.Most importantly, within the brain of a
WNV-infected host, apoptosis of neural cells is a key determinate
of viral pathogenesis, and disruption of the apoptotic pathway via
knockout of caspase-3 results in less neuronal death in several
regions of the brain and greater survival of infected mice without
significantly influencing viral loads (44). The association of
Hs_154with apoptosismay thereforemake thismiRNA a possible
candidate for therapeutic intervention.
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